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Abstract
Background: Complex microarray gene expression datasets can be used for many independent
analyses and are particularly interesting for the validation of potential biomarkers and multi-gene
classifiers. This article presents a novel method to perform correlations between microarray gene
expression data and clinico-pathological data through a combination of available and newly
developed processing tools.
Results: We developed Survival Online (available at http://ada.dist.unige.it:8080/enginframe/
bioinf/bioinf.xml), a Web-based system that allows for the analysis of Affymetrix GeneChip
microarrays by using a parallel version of dChip. The user is first enabled to select pre-loaded
datasets or single samples thereof, as well as single genes or lists of genes. Expression values of
selected genes are then correlated with sample annotation data by uni- or multi-variate Cox
regression and survival analyses. The system was tested using publicly available breast cancer
datasets and GO (Gene Ontology) derived gene lists or single genes for survival analyses.
Conclusion: The system can be used by bio-medical researchers without specific computation
skills to validate potential biomarkers or multi-gene classifiers. The design of the service, the
parallelization of pre-processing tasks and the implementation on an HPC (High Performance
Computing) environment make this system a useful tool for validation on several independent
datasets.
Page 1 of 10
(page number not for citation purposes)
BioMed  Central
Open AccessBackground
High throughput gene expression analyses carried out by
using innovative microarrays are increasingly used for
the identification of biomarkers and for their combina-
tion in prognostic or predictive classifiers, so called
signatures [1]. The usual design procedure of such
studies consists in the following three steps: i) feature
selection by statistical or artificial intelligence
approaches, ii) development of the classifier on a
training set, and iii) validation of the signature [2].
Suitable data sets are more and more available in
microarray data repositories, mainly GEO (Gene Expres-
sion Omnibus) [3,4] and ArrayExpress [5,6].
These data sets can be used to study the correlation of
clinico-pathological and follow-up data with gene
expression both for the definition of signatures and to
test hypotheses on the effects of over/under expression of
single genes. This is particularly important in the light of
the vast literature on potential biomarkers that are often
tested on very limited patient cohorts and are not
validated on independent data sets.
Different tools, implementing distinct algorithms, are
available for diverse platforms.
Web-based software would avoid this problem, but up to
date, apart from some exceptions (e.g. Expression
Profiler [7]), most of web tools are spread over different
servers and employ different file formats.
GEPAS [8] (Gene Expression Profile Analysis Suite) is an
integrated web-based pipeline for the analysis of gene
expression patterns aimed at putting the most popular
toolstogether through an integrated interface. This allows
end users to make transparently profit from the various
tools, once their data has been uploaded. This solution,
then,providesapowerfulsetofstatisticalservicesforgene
expression analysis to users. However, the single analysis,
for example survival analysis, presents some limitations
concerning, e.g., availability of various tools’ options,
flexibility in the analysis flow and support for large
datasets. Moreover, in order to customize their analyses,
users should design ad-hoc pipelines, by making use of
workflow management features, and this would imply
more complex requirements and constraints.
Another tool, Asterias [9], provides a similar suite of
applications, even if it has different implementation
language and application interface; its emphasis is put
on parallel computing.
We therefore set out to develop a flexible tool that allows
to investigate large microarray datasets – or subsets
thereof – by using standardized statistical approaches
aimed at finding out the correlation of clinical data with
gene expression results. In the final setting, researchers
should be able to select either single or several datasets,
or even single samples from different datasets, to create
their own unique dataset. They would then be able to
determine, on the basis of this new dataset, correlations
between the expression of single genes or gene lists and
clinical data.
To this aim, those limitations that are posed by current
tools must also be taken into account. In fact, most of
current statistical analyses on gene expression data is
performed by using the R language, with the support of
domain specific extension packages, such as Bioconduc-
tor [10] for life sciences. It is known that R poses serious
limitations in dealing with large amount of data; for
example, it indicates a memory failure when the required
amount of memory exceeds the address-space limit for
t h ep r o c e s so r ,m o r el i k e l y ,b e c a u s et h es y s t e mi su n a b l e
to provide a large enough contiguous block, even if there
is enough free memory available. So, we designed a
structured and engineered procedure that fully exploits
available hardware and software resources thus avoiding
many of the problems that are faced by researchers.
This limitation can be particularly relevant for normal-
ization of microarray data and calculation of gene
expression. We therefore developed a parallel version
of dChip [11] for Linux that is able to handle datasets of
the order of thousands of microarrays [12].
Microarray data analyses procedures are usually com-
posed of several steps ranging from pre-processing
(background correction, normalization, summarization)
to the statistical analysis of differential gene expression.
This may involve different computer programs, ranging
from specialized tools and statistical software environ-
ments to simple spreadsheets. It is therefore difficult to
embed them all into a single program or script. Even
when possible, this requires time and skills, it is hard to
maintain as well as unsuited for the dissemination to the
scientific community. One of the most common solu-
tions proposed to solve this issue is based on computer-
ized scientific workflows. In this approach, users can
design their virtual experiments using a specialized
software that is able to make access to standardized
services and to properly visualize resulting data. Web
based solutions able to guarantee versioning and
reproducibility of experiments have also been presented
in order to build coherent collections of experiments to
be used and re-used by the community. However, this
approach implies that all services needed must already
be available and provided either by the developer or by a
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maximum execution time and the amount of data that
can be handled by services, determined by the protocols
used for inter-processes messaging (SOAP, Simple Object
Access Protocol) and for data transfer (HTTP, HyperText
Transfer Protocol). FTP (File Transfer Protocol) and
HTTP protocols, that are presently widely used on the
Internet, were not designed for the transfer of large
datasets. If used for large data set, transfer is slow due to
the limits inherent in their processing overheads and the
transport layer protocol, TCP (Transmission Control
Protocol). This also poses limitations to tools that rely
on such data transfer solutions (e.g., the Taverna
Workbench [13]).
The goal of this research is to develop, set-up and
validate a service for automating functional genomics
analyses used in breast cancer survival studies and
prognosis assessment. We present the strategy used for
organizing heterogeneous computational steps by taking
benefit from High Performance Computing (HPC)
hardware and offering a simple user interface through
a Web portal. The current implementation only exploits
local resources; further work is underway to integrate the
service within existing e-Science Grids, such as Enabling
Grids for E-sciencE (EGEE) [14].
Results
The service
In this work, we present a methodology and an example
of application successfully used to translate an existing
procedure into an automated and consolidated Web
based process which can benefit from existing High
Performance Computing resources.
For the validation of our methodology, we explored the
possibility of obtaining information on the correlation
of single genes or lists of genes with disease free survival
after surgical removal of primary breast cancers, as
described in the Methods section, and implemented a
web tool that we called Survival Online, The main
processing steps, and other intermediate manual data
preparation steps, that are necessary for such analyses,
were analyzed, converted into web services and made
available through the BMportal, a portal developed at
the Biolab of the Department of Communication,
Computer and System Sciences (DIST) of the University
of Genoa, by using the EnginFrame framework [15]. This
tool was chosen because it is the platform adopted by
the Laboratory of Interdisciplinary Technologies for
Bioinformatics (LITBIO) project [16] and, as a conse-
quence, all newly developed services can be deployed
without any additional effort in the LITBIO portal [17],
thus reaching a large user community.
The automated procedure is shown in Figure 1 that
includes the diagram of the sequence of the processing
steps involved and their relationship. In the first step, the
parallel version of dChip is used to pre-process micro-
array data (background correction and normalization)
and to determine gene expression (by using the Perfect
Match only algorithm). The following steps further
evaluate expression values by means of several R/
Bioconductor methods. First, under/over-expressed
genes are filtered so that only a user defined set of genes
is conserved. Then, specific phenodata are associated to
samples. Finally, a Cox regression analysis, possibly
combined with a multivariate analysis, is performed
and the Kaplan-Meier survival plot is computed.
In Figure 2, the user interface for entering input
parameters and selecting analysis options is shown.
Users can browse and select data remotely or upload it
from their machine. In Figure 3, the execution spooler of
the portal is shown. Both result files and execution status
are visible.
Figure 1
Workflow of the analysis. The sequence of the analysis
steps performed is shown.
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Web portal screenshot 1. The user interface for entering input parameters and selecting analysis options. Users can browse
and select data remotely or upload it from their machine.
Figure 3
Web portal screenshot 2. The execution spooler of the portal. Both result files and execution status are visible.
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The automated procedure has been tested in order to
assess its added value. To this end, a series of gene lists
that were recently identified [18] was used. Multi-gene
analyses, as those performed here, are the first step in
signature development and need to be validated on
independent data sets: this extended validation was not
p e r f o r m e di nt h i sc a s e .R e s u l t sa c h i e v e db yu s i n g
Survival Online were identical to those obtained on
local resources, thus indicating the correct functionality
of the service.
Results were classified according to appropriate indica-
tors. Increase of performance compared to the classic
desktop-based processing was assessed by using quanti-
tative indicators, such as time spent for analysis against
different sizes of dataset, that showed a clear advantage
in using Survival Online. Tables 1 and 2 shows the
execution times obtained running the test analysis with
both the traditional procedure and Survival Online (see
Table 1). Table 2 presents a comparison between
different analysis tools such as dChip, RMA (Robust
Multi-array Average) and GCRMA (GC Robust Multi-
array Average.
Increase in usability, that is a key point in this work,
since the designed service is intended to be used as an
actual and effective support to translational research, was
also assessed. Usability tests have been performed by
staff of the Functional Genomics laboratory of the
National Cancer Research Institute of Genoa, whose
domain expertise afforded a real evaluation of the
service. As shown in Table 3, a qualitative assessment
of usability of the traditional manual procedure and of
Survival Online was carried out. Users involved in the
testing phase were asked to choose the level of
satisfaction (poor, medium, good) with reference to
three indicators: ease of use, repeatability and accessi-
bility.
Discussion
Expression analyses using complex oligonucleotide
microarrays has profoundly changed biomedical
research. Classical single gene studies necessarily start
with a hypothesis, most often based on pre-existing or
preliminary evidence or just on an intuition. Instead,
high throughput approaches, such as microarray gene
expression analyses, yield data sets that are usually
created and queried for a specific scope, yet the data is
available for other, completely unrelated analyses. Single
gene studies for the identification of biomarkers for
disease prognostication or prediction of treatment
response have therefore led to an overwhelming number
of publications where validation is usually limited to a
single study on a single dataset [19].
However, prioritization of the many biomarkers for in
depth validation and possible developments towards
clinical application is difficult. This difficulty can be
overcome by using publicly available microarray datasets
with relevant clinical-pathological data that allow for in-
silico validation of potential biomarkers for the selection
of bona fide candidates for further development. Simi-
larly, the same datasets can be used to analyze the
classification power of multigene classifiers (signatures).
We presented here a web based system, Survival Online,
where such analyses can easily be carried out by bio-
Table 1: Analysis execution times (using dChip for expression
values computation)
Indicator Desktop PC Web based
service
Web based service
(parallel dChip)
50 microarrays 24 min 10 min 5 min
150 microarrays 46 min 29 min 9 min
400 microarrays 85 min 68 min 22 min
This table shows execution times related to the execution of the
automated procedure by using a desktop PC, the web based service, the
web based service with the parallel dChip using five parallel jobs.
Execution on the desktop is carried on by an experienced operator on a
system with all needed software already up and running. It includes
intermediate manual operations and access to data stored locally on the
PC.
Web execution times are calculated starting with the same operator
already logged in to the service. Analysis is carried out on the same data,
already available on the portal.
Table 2: Analysis tools comparison
Indicator dChip RMA GCRMA
50 microarrays √√ X
150 microarrays √√ X
400 microarrays √ XX
This table shows the skill of dChip, RMA and GCRMA to execute the
analysis based on increasing number of microarrays. GCRMA doesn’t
even allow to analyze 50 microarrays, while dChip succeeds in analyzing
more than 400 microarrays.
Table 3: Qualitative assessment of usability
Indicator Desktop PC Web based service
Ease of use medium good
Repeatability poor good
Accessibility poor good
Qualitative comparison between traditional approach and the equivalent
Web based service is based on the opinions given by the users involved in
the evaluation process. Evaluation scale is based on three levels: poor,
medium, good. The comparison shows a clearly better usability of the
Survival Online tool.
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At present, the system allows to select a whole dataset or
as u b s e to fi tf o ras t r a i g h t f o r w a r da n a l y s i so fc o r -
relations between clinical and gene expression data.
Classical statistical methods (uni- and multi-variate Cox-
regression analysis, survival analysis, Kaplan-Meier
curves) are combined in a pipeline to automate the
manual procedure daily performed by researchers. The
analytical tool box will be further enriched through
the addition of advanced feature selection tools and of
classification methods based on artificial intelligence
approaches.
The validation of a classifier is better achieved when
more independent data sets are taken into account. For
this reason, our service is designed to harbour many
different datasets to be used separately or for the
generation of specific, user defined data (sub-)sets. At
present, this is limited to the widely used Affymetrix
GeneChip arrays. Other platforms can also be integrated,
but under the condition that probesets can be matched
between the different arrays by using specific conversion
tools and by correcting for batch effects.
Analyses that use very large datasets or several smaller
datasets together are normally limited by the computa-
tion power available. In our case, this limitation is
overcome by the implementation of the service on a high
performance platform and by the parallelization of the
microarray data analysis suite dChip.
We have tested our system using a breast cancer dataset
(see Methods section) retrieved from GEO. We were able
to monitor the classification power of both gene sets
selected from Gene Ontology categories and single genes
selected from literature [18]. The data shows that the
systems allows for straightforward testing of potential
biomarkers.
Functional analyses of single genes or gene lists should
always include an assessment of their effect on clinical
outcome of cancer patients. Figures 2 and 3 illustrate that
Survival Online enables the non expert biomedical
researchers to perform such analyses using existing data
sets.
In some cases, the proposed approach could be
considered better than a classical workflow approach.
First, the execution of the analysis is not demanded to a
single execution engine on the computer of the user (e.g.
Taverna client) or on a server (e.g. Taverna remote
service, Moteur [20]). Approaches to execute workflows
on distributed environments as a set of services exist (e.g.
DAG jobs [21], P-grade portal [22]) but they are not
implemented in HPC environments and are often
affected by middleware overhead and network con-
straints. Since this case study requires a high level of
interaction and usability, the best solution revealed to be
the submission of a collection of single processes on
HPC infrastructure synchronized by a scheduling system
manager.
Results show that our approach can scale up in the size
of processed data well above current available desktop
computer limitations (up to 2 computing cores and 1 GB
of RAM) just by exploiting a cluster made up of three
nodes, each composed by a low end server (2 computing
cores and 1 GB of RAM). Obviously, by using more
resources it is either possible to achieve better results or,
in some cases, to overcome the single machine limita-
tions. However, since current trends in information
technology (IT) are to offer software as a service and to
concentrate computing power into data centers, due to
cooling, power and skills requirements, it is essential to
adequate existing procedures and applications accord-
ingly. This will also avoid the spread of investments in
computing equipment inside non-IT departments and
will help to better exploit resources due to their
concentration.
Conclusion
Survival Online, allows for a straightforward execution
of complex data correlations aimed at the identification
of biomarkers and multi-gene classifiers. The system
enables bio-medical researchers to perform validations
on several independent microarray gene expression
datasets in a simple and reliable fashion by using robust
classical statistics. The collaboration between molecular
oncologists and software engineers allowed for the
optimisation of the system without loosing flexibility.
The system relies on widely used analytical tools. Results
obtained with the Web-based approach are identical to
those achieved by using the traditional methods.
Future developments are planned to enhance service
usability by using a standard WSDL (Web Services
Description Language) interface. In fact, the adopted
framework is able to provide services both through a
Web interface and through a Web Service, exploitable
from any Web Services enabled client application.
Orchestrating multiple processing steps in a workflow
strategy opens a new scenario where users can design
complex experiments, tailored to their needs, just by
using portal services as workflow building bocks.
This is possible, e.g., by importing WSDL descriptions of
services into a client application, such as the Taverna
Workbench, and by letting the portal to execute and
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enacting limitations.
In the future, we plan to implement additional feature
selection and classification tools and to add further
datasets. The development of inter-array comparison
tools is also planned.
Methods
Microarrays analysis
Microarray expression analyses of human breast cancers
were performed on the dataset GSE1456 obtained from
Gene Expression Omnibus [3]. The data set consists of
159 breast cancers from patients who received surgery at
Karolinska Hospital from 1994 to 1996 [23]. Expression
sets were calculated from raw microarray data, previously
background corrected, normalized using invariant-set
method and summarized using Perfect Match (PM) only
algorithm implemented in dChip. Samples were anno-
tated with patients’ information, including data on
disease relapse and overall and disease free survival,
representing their “phenodata”.
Survival analysis
Expression levels of previously selected genes were
combined in a weighted linear score, where weights
were determined by the coefficients of a multivariate Cox
regression model. The median value of the score was
chosen as the cut off to classify patients at low or high
risk of disease relapse. All analyses were performed with
R/Bioconductor package Survival.
Service validation
Results were classified according both to the test cases
provided and to appropriate indicators. These included:
(i) performance increase compared to the classic desk-
top-based processing (quantitative indicators, such as
time spent for analysis against different sizes of dataset,
have been adopted), (ii) increase of usability (qualita-
tive-quantitative indicators were used, with reference
both to reliability and to repeatability of experiments).
Genes contained in the lists used for tests were selected
by imposing both annotation to specified Gene Ontol-
ogy categories (cell death, metabolism, kinase, cell cell
signalling, cell growth) and significant association with
the parameter “relapse” (p < 0.001) in the Stockholm
d a t a s e t .T h eg e n el i s t“combined signatures” contains the
five most strongly relapse associated genes from the
above lists (for details see [18]) (Figure 4).
For single gene analyses, we selected the transcriptional
regulator ID4 that has been shown to regulate the
expression of the tumour suppressor gene BRCA1 [24]
(Figure 5).
Development
Starting from user requirements and available compo-
nents, it has been decided to build the service using
BMportal, the biomedical portal framework available at
Biolab [25,26], that offers basic services in different
biomedical fields that can be combined into larger
services covering complex procedures, as for the use case
here presented.
BMportal includes sophisticated data management for
all stages of job lifetime a n di si n t e g r a t e dw i t ha l l
relevant Grid and HPC workload management systems,
using plug-in modules that extend its functionality
leveraging the underlying infrastructure.
It provides a flexible presentation engine, solidly based
on leading Web and XML (Extensible Markup Language)
standards. This module provides access to the underlying
services via multiple standard languages layered on
HTTP, including HTML (HyperText Markup Language),
SOAP and RSS (Really Simple Syndication).
The authorisation system is a core component of the
architecture. It provides fine grained access control to all
services via a role-based engine, implementing both
presentation, execution and output processing layers.
The authentication system provides flexible delegation
to a rich set of external authorities, and provides internal,
session-level single-sign-on across multiple services.
The framework flexibility allows the integration of
different tools and resources that can be orchestrated in
customized complex experiments and provided as user-
friendly web-based services.
Concerning this case study, LSF from Platform Comput-
ing [27] has been used as HPC scheduler for job
submission and synchronization. Using the LSF plugin
for EnginFrame, both R/Bioconductor and dChip tools
can be submitted as LSF jobs to the HPC infrastructure,
so that every step of the analysis can be easily monitored
through the portal.
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